Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Weinrieb, R. M.
* Articles by Lucey, M. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Weinrieb, R. M.
* Articles by Lucey, M. R.
Related Collections
* Alcohol
Psychosomatics 42:110-116, April 2001
© 2001 The Academy of Psychosomatic Medicine

Alcoholism Treatment After Liver Transplantation: Lessons Learned From a Clinical Trial That Failed

Robert M. Weinrieb, M.D., Deborah H.A. Van Horn, Ph.D., A. Thomas McLellan, Ph.D., Arthur I. Alterman, Ph.D., Joseph S. Calarco, L.S.W., Charles P. O'Brien, M.D., Ph.D., and Michael R. Lucey, M.D., FRCPI

Received April 28, 2000; revised October 5, 2000; accepted October 30, 2000. From The University of Pennsylvania Department of Psychiatry and Department of Medicine, Division of Gastroenterology; Philadelphia Veterans Affairs Medical Center Department of Psychiatry; and Horizon for Mental Health, North Wales, Pennsylvania. Address correspondence and reprint requests to Dr. Weinrieb, Treatment Research Center of the University of Pennsylvania, 3900 Chestnut Street, Philadelphia, PA 19104; e-mail: weinrieb_b{at}mail.trc.upenn.edu

Alcoholic liver disease is the second most common indication for liver transplantation in the United States. The lack of alcoholism treatment studies led us to study motivational enhancement therapy (MET) plus naltrexone after transplant. The authors could not complete this study. Sixty alcoholic patients were to receive MET plus naltrexone or placebo for 6 months. Fifty men and 5 women were screened. Nine died and 15 were not approached. Of 31 approached, 20 were ineligible, 11 refused, and 5 entered but dropped out before completion. Barriers to posttransplant alcoholism included infirmity, intensive medical management, and denial for alcoholism treatment. Because 30%–50% of alcoholic patients drink after transplant, the authors suggest using MET alone pretransplant.

Key Words: Alcoholism • Liver Transplantation




This article has been cited by other articles:


Home page
FocusHome page
Ask the Expert: PSYCHIATRIC EVALUATION OF LIVER TRANSPLANT CANDIDATES
Focus, April 1, 2005; 3(2): 225 - 227.
[Full Text] [PDF]


Home page
PsychosomaticsHome page
T. P. Beresford, B. Martin, and J. Alfers
Developing a Brief Monitoring Procedure for Alcohol-Dependent Liver Graft Recipients
Psychosomatics, June 1, 2004; 45(3): 220 - 223.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2001 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org